Abstract
Half a million new cases of visceral leishmaniasis occur each year, and 10% of these are fatal. New tools are urgently needed for mapping, diagnosing, and treating the disease.
MeSH terms
-
Animals
-
Antiprotozoal Agents / therapeutic use
-
Dogs
-
Drug Industry
-
Humans
-
Leishmania
-
Leishmaniasis, Visceral / diagnosis*
-
Leishmaniasis, Visceral / epidemiology
-
Leishmaniasis, Visceral / therapy*
-
Leishmaniasis, Visceral / transmission
-
Models, Biological
-
Phlebotomus
-
Public Health